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A Long CAG Repeat in the Mouse Sca1 Locus
Replicates SCA1 Features and Reveals the Impact of
Protein Solubility on Selective Neurodegeneration
ataxias types 2, 3, 6, 7, and 17 (Zoghbi and Orr, 2000;
Nakamura et al., 2001). The primary site of pathology
varies somewhat from one disorder to the next, even
though the respective disease-causing proteins are
widely expressed; in SCA1, the mutant ataxin-1 protein
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One of the most fruitful approaches to studying poly-University of Minnesota
glutamine diseases has been to generate transgenicMayo Mail Code 206
mouse models expressing truncated or full-lengthMinneapolis, Minnesota 55455
cDNAs encoding the mutant protein in neurons (review;
Lin et al., 1999; Gusella and MacDonald, 2000). Most of
these transgenic mice overexpress the mutant proteinSummary
under either neuron-specific or ubiquitous promoters,
which is enough to reproduce various aspects of theTo faithfully recreate the features of the human neuro-
human neurological phenotypes, including aggregatedegenerative disease spinocerebellar ataxia type 1
formation in neurons. The role of these aggregates in(SCA1) in the mouse, we targeted 154 CAG repeats
the disease process has been controversial; althoughinto the endogenous mouse locus. Sca1154Q/2Q mice de-
data suggest that the aggregates themselves are notveloped a progressive neurological disorder that re-
necessary for initiating disease (Klement et al., 1998),sembles human SCA1, featuring motor incoordination,
their role in pathogenesis remains unclear, and muchcognitive deficits, wasting, and premature death, ac-
effort has been directed toward interventions that seekcompanied by Purkinje cell loss and age-related hip-
to eradicate these deposits.pocampal synaptic dysfunction. Mutant ataxin-1 solu-
To model SCA1, Burright et al. (1995) generated trans-bility varied with brain region, being most soluble in the
genic animals that overexpress mutant ataxin-1 tran-neurons most vulnerable to degeneration. Solubility
scripts under the control of the Purkinje cell pcp2 pro-decreased overall as the mice aged; Purkinje cells, the
moter. One of these transgenic lines, the B05 line,
most affected in SCA1, did not form aggregates of
expresses a full-length mutant ataxin-1 mRNA with 82
mutant protein until an advanced stage of disease. It CAG repeats (82Q) at around 50–100 times endogenous
appears that those neurons that cannot sequester the levels in Purkinje cells after postnatal day (P)10 and
mutant protein efficiently and thereby curb its toxicity develops the ataxia typical of human SCA1. These mice
suffer the worst damage from polyglutamine-induced allowed the discovery that several specific genes are
toxicity. downregulated in Purkinje cells before any detectable
pathological changes (Lin et al., 2000), which suggests
Introduction that mutant ataxin-1 may initiate the disease process
by altering gene expression. Studies of the B05 mice
Spinocerebellar ataxia type 1 (SCA1) is one of several also provided early evidence that misfolding and im-
dominantly inherited, late-onset neurodegenerative dis- paired degradation of mutant ataxin-1 might underlie
orders caused by the expansion of a CAG trinucleotide SCA1 pathogenesis (Cummings et al., 1998). This hy-
repeat that encodes polyglutamine in the respective dis- pothesis was supported by recent studies showing that
ease proteins. At least eight other disorders result from the disease phenotype of B05 mice was aggravated by
this pathogenic mechanism: spinobulbar muscular atro- dysfunction of the ubiquitin-proteasome (UPP) pathway
phy (SBMA), Huntington’s disease (HD), dentatorubral (Cummings et al., 1999) but suppressed by overexpres-
pallidoluysian atrophy (DRPLA), and the spinocerebellar sion of inducible Hsp70 chaperone (Cummings et al.,
2001).
Although the B05 mice have been useful for disclosing8 Correspondence: hzoghbi@bcm.tmc.edu
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disease mechanisms, they show only the phenotype between levels of the wild-type and mutant protein in
brain, we extracted proteins from mutant brains at threeassociated with dysfunctional Purkinje cells and usually
live a normal lifespan. This makes direct comparison different ages and analyzed them by immunoblotting
(Figure 1D). Although mutant ataxin-1 created a distinct,with human SCA1 difficult, since human SCA1 patients
develop cognitive impairment as the disease pro- strong band in a 2-week-old mouse brain, it became
fainter as the mice got older and was barely detectablegresses, and the final stage of the disease is quite com-
plex, causing patients to die early. In theory, a “knockin” at 25 weeks of age. This is not likely due to any age-
dependent increase in mutant ataxin-1 degradation,approach, in which the human mutation is introduced
into the corresponding mouse gene, should provide a since immunohistochemical analysis with 11NQ re-
vealed dense staining, often with intranuclear inclusionmore accurate genetic model. Expression from the en-
dogenous locus should guarantee accurate temporal formation, in various neuronal populations from 12-
week-old Sca1154Q/154Q mouse brains (see also below).and spatial expression patterns at endogenous levels
and help us dissect the mechanisms of cell-specific Rather, this difference in the densities of monomeric
mutant and wild-type bands likely derives from differ-vulnerability or selective neurodegeneration. To this
end, we generated knockin mice carrying 78 CAG re- ences in extraction or solubilization rather than actual
levels of those proteins: the mutant protein accumulatespeats in the mouse Sca1 locus (Lorenzetti et al., 2000).
Although these Sca178Q/2Q mice express expanded into nuclear aggregates and becomes less extractable
as mutant animals get older. In order to analyze aggre-ataxin-1 at endogenous levels in a proper spatial and
temporal pattern, they show only mild behavioral gated forms of mutant ataxin-1 on immunoblot, we next
utilized brain extracts prepared with urea/SDS-con-changes late in life. Hypothesizing that the short lifespan
of the mouse does not allow sufficient time for its neu- taining buffer. Brain extracts from mutants, but not con-
trol littermates, gave distinct ataxin-1 immunoreactivityrons to accumulate significant damage, we targeted an
expanded repeat of 154 CAGs into the mouse locus. (ATX-1 IR) in the top part of the stacking gels (Figure 1F).
Densities of the ATX-1 IR got stronger as the mutantsThese Sca1154Q/2Q mice reproduced many aspects of the
human disease and shed light on several aspects of became older, indicating age-dependent increases in
mutant ataxin-1 aggregation.polyglutamine-induced pathogenesis, including the re-
lationship between aggregate formation and neuronal Since ataxin-1 is highly abundant in neurons, we also
compared the expression and extractability of ataxin-1dysfunction.
among various brain regions of 3-week-old mice to see
if there are any regional differences that could accountResults
for selective neuronal dysfunction or degeneration. As
shown in Figure 1E, levels of wild-type ataxin-1 varyGeneration of Sca1154Q/2Q Mice and Analysis
among brain sub-regions, with high levels in cerebralof Mutant Protein
cortex, basal ganglia, hippocampus, and cerebellum.An expanded repeat of 154 CAGs was targeted into the
There are considerable differences in the extractabilitymouse Sca1 locus (Sca1154Q) as previously described
of mutant ataxin-1 in different brain regions. Mutant(Lorenzetti et al., 2000). Chimeric mice were generated
ataxin-1 gave fainter bands (i.e., was less extractable)by microinjection of correctly targeted ES cells into
in the basal ganglia and cerebral cortex than in theC57Bl/6J blastocysts and were mated to C57Bl/6J fe-
cerebellum, brain stem, spinal cord, and olfactory bulb.males (Figure 1A). Crosses between F1 mice carrying an
Sca1154Q allele produced wild-type, heterozygous, and
homozygous offspring in expected proportions (data not Neurological Phenotype of Sca1154Q/2Q Mice
Up to 7 weeks of age, the mutant mice were indistin-shown).
Expression of the mutant transcript was assessed by guishable from their wild-type littermates in home cage
behavior. At 8 weeks of age, they began to show growthRT-PCR using primers flanking the CAG repeat. Total
RNA was extracted from a 7-week-old Sca1154Q/2Q mouse retardation. By 11 weeks of age, they weighed about
20% less than their wild-type littermates (Figure 2B).brain. As shown in Figure 1B, both mutant and wild-
type transcripts produced almost equivalent band inten- The body weight of the Sca1154Q/2Q mice peaked at around
20 weeks of age, after which the mice gradually lostsities, suggesting that mutant and wild-type alleles were
similarly transcribed. The expression of mutant ataxin-1 weight as the disease progressed.
By the ninth week, the mutants started showing awas confirmed by Western analysis of mutant mouse
brain extracts, which were prepared with 0.25 M Tris- clasping phenotype when suspended by the tail. The
neurological phenotype progressed to a generalizedcontaining buffer (Figure 1C). Surprisingly, in the adult
mouse brain, the 11750 antibody, which was raised muscle wasting, ataxia, and abnormal gait by 20 weeks
of age. We observed severe kyphosis (curvature of theagainst the C-terminal portion of ataxin-1 (Servadio et
al., 1995), recognized mutant ataxin-1 as a much fainter spine) accompanied by atrophy of lower limb muscles
in the mutant animals at about 30 weeks (Figure 2A).150 kDa band than its wild-type counterpart. This band
also displayed immunoreactivity when the same blot Premature death occurred between 35 and 45 weeks of
age (Figure 2D). None of the mutant animals survivedwas stripped and reprobed with 1C2 antibody, which
detects long polyglutamine tracts. Neither 1C2, 11750, past 50 weeks. The mice did not manifest any obvious
seizures.or the 11NQ antibody (which detects the N-terminal por-
tion of ataxin-1) revealed any cleaved products derived Naı¨ve Sca1154Q/2Q mice were tested on the accelerating
rotarod apparatus at 5 and 7 weeks of age (Figure 2C).from mutant ataxin-1.
To gain further insight into the apparent difference Although they had no overt gait ataxia at that time, their
Knockin SCA1 Mouse and Selective Degeneration
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Figure 1. Generation and Expression of an Expanded CAG Allele at the Sca1 Locus
(A) This schematic represents the targeting construct, the endogenous Sca1 allele, and the predicted structure of the mutant CAG expansion
allele generated by a homologous recombination and a Cre-mediated excision event.
(B) RT-PCR analysis was performed on brain RNA from a 7-week-old Sca1154Q/2Q knockin mouse (Sca1154Q/2Q) and a wild-type littermate (wt)
with () or without () reverse transcriptase. The forward primer is located in exon 7, while the reverse primer sits right after the CAG repeat
sequence in exon 8. The reaction gives 968 bp for the wild-type allele (arrow) and 1421 bp for the Sca1154Q allele (arrowhead).
(C) Western blot analysis was performed on whole brain extracts from a 7-week-old Sca1154Q/2Q knockin mouse (Sca1154Q/2Q) and a wild-type
littermate (wt), both probed with the 1C2 monoclonal antibody (left) and the 11750 antibody (right). Arrowhead and arrow indicate the mutant
and wild-type ataxin-1 protein, respectively. The 1C2 antibody revealed nonspecific cross reactant (asterisk). Marker bands indicate 189, 119,
and 85 kDa, respectively.
(D) Whole brain extracts (100 g) from 2-, 9-, and 25-week-old Sca1154Q/2Q knockin mice show an age-dependent decrease in the detectability
of mutant ataxin-1 on an immunoblot probed with the 11750 antibody. Arrowhead and arrow indicate the mutant and wild-type ataxin-1
protein, respectively.
(E) Western blot analysis of protein extracts (80 g) from various parts of a 3-week-old Sca1154Q/2Q mouse brain display differential mutant
protein solubility. Abbreviations are as follows: OB, olfactory bulb; BG, basal ganglia; HP, hippocampus; CX, cerebral cortex; PS, pons; CB,
cerebellum; SC, spinal cord. Arrowhead and arrow indicate the mutant and wild-type ataxin-1 protein, respectively. Relative densities of upper
bands (mutant ataxin-1) compared to lower bands (wild-type protein) are as follows: OB, 0.29; BG, 0.09; HP, 0.21; CX, 0.09; PS, 0.29; CB,
0.58; SC, 0.36.
(F) Aggregated ataxin-1 was detected on immunoblot using the 11NQ antibody is depicted. Brain homogenates (150 g) from 2-, 20-, and
40-week-old Sca1154Q/2Q knockin mice (Sca1154Q/2Q) and wild-type littermate (wt) were prepared in buffer containing urea/SDS and analyzed by
SDS-PAGE.
performance was significantly poorer than that of age- (p  0.000002) indicates that the performance of the
matched wild-type littermates at both 5 and 7 weeks of two genotypes was dependent on the trial number.
age (p  0.0005 and p  0.0001, respectively). Sca1154Q/2Q mutants took more time and swam a greater
distance to find the platform during the early trials (i.e.,
in trial blocks 1–6, p  0.05) but performed as well asLearning and Memory in Sca1154Q/2Q Mice
wild-type mice on trial blocks 7 and 8 (p 0.21) (FiguresSince cognitive impairment is one of the clinical features
3A and 3B). There was no overall difference (p  0.564)of SCA1, we assayed the cognitive function of Sca1154Q/2Q
in swim speed between Sca1154Q/2Q and wild-type micemice. Spatial learning performance was assessed using
(Figure 3C), suggesting that simple motor impairmentthe Morris water maze. Since Sca1154Q/2Q mutants have
was not interfering with the performance of the mutantnotable motor impairment, we tested a group of
mice on this test.Sca1154Q/2Q mice at 7–8 weeks of age on a visible platform
The hidden platform test measures the ability of antask in which the animals are required to find a slightly
animal to learn the spatial relationship between ex-submerged fixed platform whose location is marked by
tramaze cues and the platform. Performance is as-a large proximal cue (see Experimental Procedures).
sessed by recording the time it takes to locate the plat-Overall, the Sca1154Q/2Q mutants took considerably
form during training and characterizing the searchlonger to locate the platform than wild-type mice (p 
0.000001) (Figure 3A), but a genotype X trial interaction pattern during a probe trial that is given after training.
Neuron
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Figure 2. Phenotype of Sca1154Q/2Q Mice
(A) These photographs are representative of
28-week-old Sca1154Q/2Q mice and their wild-
type littermates.
(B) Sca1154Q/2Q mice displayed progressive
weight loss. Error bars indicate standard de-
viation.
(C) Sca1154Q/2Q mice showed impaired perfor-
mance on the accelerating Rotarod appara-
tus. Performances of 5-week-old (left, n  8
in each group) and 7-week-old (right, n  10
in each group) mice are shown. Mice were
trained in four trials per day (A–D) for 5 days
(D1–D5). Naı¨ve mutant mice and their wild-
type littermates were tested in each test. Er-
ror bars indicate SEM.
(D) Sca1154Q/2Q mice had reduced lifespan. Per-
centage of Sca1154Q/2Q knockin (dashed line,
n 10) and wild-type (black line, n 10) mice
surviving at various ages is shown.
Sca1154Q/2Q mutant mice (at 7–9 weeks of age) took signifi- immediately upon termination of the auditory CS. The
animals are presented a second CS-US pairing 2 mincantly more time (Figure 3D) to locate the hidden plat-
form than wild-type mice (p  0.0000004). Figures 3E later. The mouse is then removed from the chamber
and returned to its home cage; after a specified delayand 3F show that during the probe trial, not only did wild-
type mice spend significantly more time in the training interval, the memory of the training experience is as-
sessed using two test sessions (see Experimental Pro-quadrant than the Sca1154Q/2Q mutant mice (p  0.025),
but they also crossed the exact place where the platform cedures). For the present study, 6- to 8-week-old
Sca1154Q/2Q mutants and wild-type mice were trained andhad been located more often than Sca1154Q/2Q mutant
mice (p  0.001). These data indicate that Sca1154Q/2Q then tested either 1 hr or 24 hr later. The results from the
context test (Figure 3G) show that there was a significantmice have impaired spatial learning performance.
The conditioned fear test assays Pavlovian learning genotype X delay interval interaction (p  0.0436).
Sca1154Q/2Q mice displayed significantly less freezing thanand memory. Mice are placed in a test chamber (context)
which they are allowed to explore freely. After 2 min, an wild-type mice during the context test after a 24 hr delay
(p  0.026), but not after a 1 hr delay (p  0.883). Inauditory conditioned stimulus (CS) is presented and a
mild footshock unconditioned stimulus (US) is delivered contrast to the findings for the context test, there was no
Knockin SCA1 Mouse and Selective Degeneration
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Figure 3. Impaired Learning and Memory in
Sca1154Q/2Q Mice
(A and B) Latency (A) and distance (B) trav-
eled to find the visible platform differed for
Sca1154Q/2Q and wild-type (WT) mice. (C) indi-
cates swim speed in the visible platform task
for Sca1154Q/2Q and WT mice.
(D) Latency to find the hidden platform in the
Morris water task for Sca1154Q/2Q and WT mice
is shown. (E and F) This graph presents quad-
rant search time (E) and number of platform
crossings for the training quadrant (F) after
hidden platform training in the Morris water
task for mutant and wild-type mice. (G) and
(H) show Pavlovian conditioned fear for
Sca1154Q/2Q and wild-type (WT) mice with per-
centage of intervals spent in freeze during
the context test (F) and CS test (G). All data
are expressed as the mean (SEM).
genotype X delay interval interaction for the conditioned A hallmark of polyglutamine disease is the appear-
ance of neuronal intranuclear inclusions (NIs). No NIsstimulus (p  0.687) (Figure 3H). Thus, the difference
between Sca1154Q/2Q and wild-type mice depends on the were observed in 5-week-old mouse brains, but ubiquiti-
nated NIs were abundant in CA1 hippocampal neuronstype of test (context versus CS) and the delay interval
(24 hr versus 1 hr). at 7 weeks of age (see below). We therefore examined
the electrophysiological responses of CA1 neurons at 8
weeks of age. Mutant animals had normal input-outputHippocampal Synaptic Function in Sca1154Q/2Q Mice
It was previously shown that ataxin-1 is required for functions, PPF, and LTP (Figures 4C and 4D), suggesting
that NIs do not alter synaptic transmission or plasticity atnormal short-term synaptic plasticity in hippocampal
CA1 neurons; ataxin-1 knockout mice displayed im- this age. Older (24-week-old) Sca1154Q/2Q mice, however,
exhibited a decrease in the input-output functions forpaired paired pulse facilitation (Matilla et al., 1998). We
hypothesized that the electrophysiological properties of stimulation of Schaffer collateral inputs into area CA1
(Figure 4E, p  0.02), suggesting that basal synapticCA1 neurons might be altered by a dominant-negative
or gain-of-function mechanism in mutant ataxin-1. We transmission is impaired in the older Sca1154Q/2Q mutant
hippocampus. The derangement in synaptic transmis-therefore examined the effect of the mutation on the
synaptic function of CA1 neurons using extracellular sion manifested itself as an alteration in the pEPSP rela-
tive to fiber volley amplitude (Figure 4E). In addition,recordings from hippocampal slices. First, we tested
hippocampal slices from 5-week-old animals. We ob- mutant slices exhibited a decrease in maximum EPSP
response (Figures 4E and 4G).served no significant difference between 5-week-old
Sca1154Q/2Q mice and wild-type controls in baseline syn- Although derangement in baseline synaptic transmis-
sion may complicate evaluation, we proceeded to LTPaptic transmission, paired pulse facilitation (PPF), or
long-term potentiation (LTP) (Figures 4A and 4B). analysis in the 24 week-old Sca1154Q/2Q mutants. Tetanic
Neuron
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Figure 4. Effect of the Knockin Mutation on Hippocampal Physiologic Responses in Area CA1
Hippocampal slices obtained from Sca1154Q/2Q mice (open circle) or wild-type mice (closed circle) were utilized in experiments to evaluate
baseline synaptic function and short- and long-term forms of synaptic plasticity. Baseline synaptic transmission was determined by analyzing
the slope of the population excitatory postsynaptic potential (pEPSP) compared to the amplitude of the fiber volley. 5- and 8-week-old Sca1154Q/2Q
mutants show no significant differences in synaptic transmission (A and C). Paired-pulse facilitation (PPF) was unaffected in all age groups
tested: 5-, 8-, and 24-week-old Sca1154Q/2Q mutants (insets in [A], [C], and [E]). Derangement of synaptic transmission was seen in 24-week-
old Sca1154Q/2Q mutants (E). Representative pEPSP traces (mean of six successive EPSPs) of baseline synaptic transmission for each age group
are shown (insets in [B], [D], and [F]) (scale bars are 1 mV and 10 ms). Long-term potentiation (LTP) induced in stratum radiatum of area CA1
of the hippocampus using 100 Hz stimulation (indicated by an arrow) is normal in 5-week-old Sca1154Q/2Q animals (B) and 8-week-old Sca1154Q/
2Q animals (D), but LTP was significantly reduced in 24-week-old mutants (90 min: WT 163  7.4, n  7 and Sca1154Q/2Q 137  9.1, n  9, p 
0.026) (F). Input-output curves were generated from 24-week-old Sca1154Q/2Q knockin mice by measuring the slope of the pEPSP at increasing
stimulus intensities (G). (see a) The stimulus intensity needed to elicit 50% of the maximum pEPSP slope for wild-type animals was determined
Knockin SCA1 Mouse and Selective Degeneration
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stimulation in slices from the 24-week-old animals elicited bellar Purkinje neurons at a relatively early age (6 to 11
weeks) using whole-cell recordings in cerebellar slices.normal post-tetanic potentiation (PTP), but a reduced po-
tentiation was seen immediately following high-frequency We first compared passive membrane properties of Pur-
kinje cells by recording membrane currents in responsestimulation (HFS). This diminution of potentiation lasted
90 min post-tetanus (Figure 4F). to hyperpolarizing voltage steps from the holding poten-
tial of 70 to 80 mV. As reported previously (Llano etOur usual LTP-induction protocol uses a stimulus in-
tensity that elicits 50% of the maximum pEPSP to al., 1991), the decay of the current was biphasic and
could be described by the sum of two exponentials (dataevaluate both baseline synaptic transmission and the
period of LTP-inducing, 100 Hz high-frequency stimula- not shown). From their time constants, we calculated
several parameters representing passive properties oftion. As shown in Figure 4G, the maximum pEPSP slope
in 24-week-old mutants was considerably lower than Purkinje cells based on the model equivalent circuit of
PCs described by Llano et al. (1991) (Table 1). This modelthat of the wild-type controls. In other words, beginning
with a lower absolute EPSP magnitude, the Sca1154Q/2Q distinguishes two regions in the Purkinje cell. Region 1
represents the soma and the main proximal dendrite;mutants achieved 50% of the maximum slope of the
pEPSP and thus achieved a lower EPSP magnitude dur- region 2 represents the main part of dendritic tree. The
lumped membrane capacitance of regions 1 and 2 wereing LTP-inducing high-frequency stimulation. This could
underlie the difference in Sca1154Q/2Q LTP induction, since calculated as C1 and C2, respectively. We found that
the lumped membrane capacitance of the dendritic treethe EPSP magnitude during stimulation could have an
effect on the overall potentiation produced. Therefore, in (C2) was significantly smaller in Sca1154Q/2Q mice than wild-
type mice (p  0.01, t test) (Table 1). Given the discern-our next set of experiments, we determined the stimulus
intensity required to elicit 50% of the maximum pEPSP ible reduction of dendritic arbor at advanced stages of
disease, these results likely reflect a reduction in thein our wild-type group (Figure 4G, arrow at a) and then
adjusted the stimulus used in our Sca1154Q/2Q mutants to average total membrane area of the dendritic tree in
young Sca1154Q/2Q mice.give a pEPSP with a similar EPSP slope (see baseline
in Figure 4H). We found that the stimulus intensity re- We then assessed the kinetics and short-term plastic-
ity of climbing fiber-mediated (CF) and parallel fiber-quired to give approximately equal pEPSPs (950 mV/
ms) was 12.5 and 17.5 mA for wild-type and Sca1154Q/2Q mediated (PF) EPSCs. The decay time constant was
obtained by fitting the decay phases of the EPSCs withmutants, respectively. At the stated stimulus intensities,
the recorded baseline pEPSPs were indistinguishable single exponentials. We observed no significant differ-
ence between those young Sca1154Q/2Q mice and wild-for both animal groups prior to high-frequency stimula-
tion (HFS) (Figure 4H). type controls in the kinetics of the rise and decay times
for both the CF- and PF-EPSCs (Table 1), paired-pulseWhen the absolute pEPSP magnitude of control and
knockin animals was compared, there was a significant facilitation of PF-EPSC, or in paired-pulse depression
of CF-EPSC (data not shown). The degree of multipledecrease in the pEPSP magnitude in the mutant animals
90 min after HFS (Figure 4H, p  0.02). Moreover, using climbing fiber innervation of Purkinje cells was similar
between wild-type mice and Sca1154Q/2Q mice (data notthe 17.5 mA stimulus intensity, the Sca1154Q/2Q mice
showed a complete loss of potentiation to baseline lev- shown). In addition, there was no significant difference
between the two mouse strains in the chord conduc-els by 30 min post-HFS. These results suggest that the
hippocampal LTP deficit observed in the 24-week-old tance for CF-EPSCs (Table 1). These results suggest
that synapse formation and function at this age are notSca1154Q/2Q mice reflects a deficit in HFS-dependent syn-
aptic plasticity. It is important to note that for the second altered in the mutant animals.
experiment, where EPSP magnitudes were comparable,
the apparent deficit in LTP could be due to the CA1 Nuclear Inclusions in Different Brain Regions
Immounohistochemical analysis of ataxin-1 in controlSchaffer collateral synapse already being near the maxi-
mal response, which would manifest as an inability to adult mouse brains shows that ataxin-1 localizes pre-
dominantly to the nuclei of neurons throughout the ner-reach an appreciable HFS-induced potentiation.
vous system. We detected neuronal NIs by immunohis-
tochemistry in multiple neuronal populations in mutantElectrophysiology of Purkinje Cells in Young
Sca1154Q/2Q Mice brains. By light microscopic analysis, NIs were first evi-
dent as a single, small dot at 6 weeks of age in corticalSca1154Q/2Q mice developed motor incoordination at 5
weeks of age. At this stage, the Purkinje cells appeared neurons, CA1 hippocampal neurons, and thalamic nu-
clei. In end-stage brains, we observed large NIs withgrossly normal by calbindin immunofluorescence, though
we could not rule out subtle changes in distal dendrites dense staining in these neurons. In addition, we ob-
served inclusions within neurons in various other regions(see below). To probe the mechanism underlying im-
paired motor coordination in young mutant animals, we (caudate, putamen, cerebellum, brain stem, and spinal
cord). Mapping of NIs in the mutant brains revealedexamined the electrophysiological properties of cere-
to be 12.5 mV (G, a), compared to 17.5 mV needed to elicit a pEPSP with a similar slope for Sca1154Q/2Q mice. With pEPSP slopes being equal,
HFS-induced potentiation showed a significant reduction in Sca1154Q/2Q mice (H). The pEPSPs immediately following HFS were significantly
reduced in Sca1154Q/2Q mutants (wt 2411  277.0, n  7 and Sca1154Q/2Q 460  280.9, n  5, p  0.02) and were consistent for the duration of
the experiment (90 min post-tetanus: wt 1481  171.7, n 7 and Sca1154Q/2Q 959  120.4, n 5, p  0.02) (Data points and error bars represent
the mean  SEM).
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Table 1. Electrophysiological Parameters of the Purkinje Cell
Wild-Type Sca1154Q/2Q
a Passive membrane properties n  14 n  16
C1 (pF) 184  19 164  16
C2 (pF) 1038  60** 776  50**
R1 (M) 6.8  0.3 6.6  0.3
R2 (M) 7.4  0.5 8.4  0.6
R (M) 219.8  22.0 408.4  97.7
CF-EPSC n  24 n  24
10%–90% rise time (ms) 0.4  0.01 0.4  0.01
b Decay time constant (ms) 5.4  0.20 5.0  0.24
c Chord conductance (nS) 111.6  7.4 100.3  11.4
PF-EPSC n  10 n  8
10%–90% rise time (ms) 1.0  0.04 1.0  0.13
b Decay time constant (ms) 8.9  0.93 8.5  0.92
a Parameters for passive membrane properties were calculated according to the model described by Llano et al. (1991), which distinguishes
two regions of Purkinje cells: region 1, which represents the soma and the main proximal dendrites, and region 2, which represents the
dendritic tree. C1 and C2 represent the lumped membrane capacitance of regions 1 and 2, respectively. R1 represents the pipette access
resistance. Region 2 is linked to region 1 by resistor R2, which represents the lumped resistance between the main proximal dendrite and
each membrane region of the distal dendrites. R3 represents the lumped resistance of the dendritic tree of PCs. The values of C1, C2, R1,
and R2 were calculated from the inital capacitive currents in response to hyperpolarizing voltage steps (500 ms duration) from 70 to 80
mV. The value of R3 was measured from the steady state currents in response to hyperpolarizing voltage steps (500 ms duration) from 80
to 85 mV.
b Decay time constants for CF- and PF-EPSCs were measured by fitting the EPSC decay with a single exponential. Holding potential was 80
mV.
c Chord conductance was measured from CF-EPSCs recorded at the holding potentials of 20 mV and 40 mV.
All data are expressed as mean  SEM.
**p  0.01 (t test).
considerable differences between neuronal groups in plex in the NI that might allow only limited access to
antibodies.the appearance and abundance of NIs. For example,
neither hypothalamic or cerebellar granule neurons de- In several other polyglutamine diseases, CREB bind-
ing protein (CBP) has been found to be sequesteredvelop Nis, but this is not surprising because ataxin-1 is
expressed at very low levels in these neurons. Since it into NIs, and interference of CBP-mediated transcription
may be involved in neuronal toxicity (McCampbell et al.,is known that in SCA1, marked neurodegeneration oc-
curs in specific areas (Purkinje cells, red nucleus, olivary 2000; Nucifora et al., 2001). We stained brain sections
derived from 7-, 20-, and 40-week-old Sca1154Q/2Q micecomplex, and motor neurons in the anterior horn), we
examined NI formation in the analogous mouse neurons with two antibodies, A-22 and C-20 (Santa Cruz, CA),
that recognize either the amino- or carboxyl-terminusto examine the relationship between NIs and neurode-
generation. Interestingly, we detected NIs less fre- of the protein. Although the CBP-IR was largely re-
stricted to the nucleus, none of the ataxin-1 NIs werequently in these most susceptible neuronal groups than
in cortical or hippocampal pyramidal neurons, which stained with them (data not shown).
show only mild neurodegeneration in SCA1 patient tis-
sue (Figure 5). Less than 0.5% of Purkinje cells harbored
tiny NIs before 20 weeks of age, while more than 80% Neuropathology of Sca1154Q/2Q Mice
We examined several mutant and wild-type mouseof the neurons in the cerebral cortex and hippocampus
contained NIs at the same age. brains from different age groups, ranging from 4 weeks
(juvenile) to 42 weeks (end-stage). Juvenile mutant miceNIs in the knockin mice stained positive for ubiquitin
(Figure 5M), as they do in B05 mouse and human tissue. showed no gross abnormalities, but brains from end-
stage mutants were consistently smaller than those fromAntibodies to HDJ2 chaperone failed to reveal any NIs
in 7-week-old-brains, merely diffusely staining the cyto- littermate controls. 16-week-old mutants had signifi-
cantly reduced brain weight (p  0.00002 by ANOVA,plasm (Figure 5N). As the NIs grow over time, some of
NIs in the mutant hippocampus, cortex, and inferior olive Figure 6E). Brain sections obtained from the aged mice
(40 weeks) showed uniform atrophy, with dilatation ofbecome positive for HDJ2 by 18 weeks of age. In mutant
brains from 40 weeks of age, most of the NIs in those all the ventricles (Figure 6F).
Inspection with anti-calbindin immunofluorescenceareas (but not those in Purkinje cells) were recognized
by the antibodies. Hsc70, which was also detected in uncovered no gross pathological changes in Purkinje
cells from 17-week-old Sca1154Q/2Q mice (data not shown).ataxin-1 nuclear aggregates in Purkinje cells of B05
mice, was observed in most hippocampal or cortical NIs Using quantitative analysis, however, on cerebellar
slices from the 19-week-old animals (see Experimentalin 40-week-old, but not 7-week-old, mutant brains (data
not shown). These results suggest that the involvement Procedures), we found that wild-type Purkinje cells had
dendritic arbors with approximately 50% higher fluores-of HDJ2 chaperone as well as Hsc70 in NI may be sec-
ondary to the initial formation of NI or sequestration cence than their mutant counterparts (Figure 6G). Similar
alterations were noted on slices from a pair of 9-week-of ubiquitin. Alternatively, during the initial phase of NI
formation, these chaperone proteins may be in a com- old animals (data not shown). The lower fluorescence
Knockin SCA1 Mouse and Selective Degeneration
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Figure 5. Characterization of NIs in Sca1154Q/2Q Brains
(A–K) NI distributions in Sca1154Q/2Q brains show temporal and regional patterns. Paraffin sections from cerebellar cortex (A, D, and H), cerebral
cortex (B, E, and I), CA1 hippocampus (C, F, and J), and anterior horn of spinal cord (G and K) were stained with anti-ataxin-1 antibody 11NQ.
Brains were collected at 5 (A–C), 21 (D–G), and 40 (H–K) weeks of age. Inclusions appear later in anterior horn neurons and Purkinje cells
than in cortical neurons and hippocampal CA1 neurons. (L–O) NIs were revealed in CA1 hippocampal neurons of 7-week-old Sca1154Q/2Q mice
by anti-ataxin-1 antibody 11NQ (L) or anti-ubiquitin antibody (M), but not by anti-HDJ-2 antibody (N). In a 40-week-old mutant’s brain, most
of the CA1 neurons possessed NIs stained with anti-HDJ-2 antibody (O). Insets show individual CA1 neurons at higher magnification. Original
magnification for each photograph was 200.
in mutant Purkinje cells indicates the paucity of fine rons to mutant ataxin-1 toxicity. Purkinje cell loss did
not appear to result from apoptotic mechanisms, baseddendritic arbor.
By 34 weeks of age, dendritic arborization was obvi- on negative Tunel staining (data not shown). Reactive
astrocytosis was detected in the spinal cord by glialously reduced in cerebella from mutant animals (Figures
6A–6D) and Purkinje cell loss was noticeable. We quanti- fibrillary acidic protein (GFAP) immunoreactivity; stain-
ing was most intense in the dorsal columns, but we alsofied cell loss among Purkinje neurons and hippocampal
pyramidal neurons on midsaggital sections stained with observed enhanced immunoreactivity in the ventral part,
including the anterior horn. There was no increase inhaematoxylin and eosin (HE) in 40-week-old mutants
and their littermates. There were significantly (p  0.01) GFAP staining in other brain regions such as the cerebel-
lum and brain stem.fewer Purkinje neurons in the mutant cerebella (wild-
type; 255.3 9.4, Sca1154Q/2Q mice; 196.8 11.6, mean
SEM, per section; n  4 animals). The relatively intact Discussion
population of hippocampal pyramidal neurons in the
mutant brains (wild-type; 497.3  12.3, Sca1154Q/2Q mice; Sca1154Q/2Q mice develop a devastating neurological dis-
ease remarkably reminiscent of SCA1. Like SCA1 pa-461.7  34.2, mean  SEM, per section; n  3 animals)
underscores the greater vulnerablility of Purkinje neu- tients, Sca1154Q/2Q mice develop a complex, slowly pro-
Neuron
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Figure 6. Neurodegenerative and Atrophic Changes in Sca1154Q/2Q Brains
(A–D) Immunofluorescence confocal microscopy of 34-week-old Sca1154Q/2Q mouse (A and B) shows altered cerebellar morphology (compared
with wild-type mouse in [C] and [D]). Staining was performed with antisera against calbindin. Scale bars indicate 100 m. (E) At 16 weeks,
Sca1154Q/2Q mice showed a statistically significant reduction in brain weight compared to wild-type littermates. Error bars indicate SEM. (F) Mid-
sagittal sections from the mutant and wild-type brains (40-week-old) highlight marked atrophy in the mutants. (G) Calbindin immunofluorescence
obtained from selected rectangular subsections of wild-type or the mutant cerebella was quantified and averaged (n  6, in each group).
Calbindin immunofluorescence was reduced in 19-week-old Sca1154Q/2Q mice.
gressive neurodegeneration. Motor incoordination is fear (Frankland et al.,1998; Logue et al.,1997; Jiang et
al.,1998) and impaired spatial learning in the hidden-apparent as early as 5 weeks of age on the rotarod
test and later becomes frank gait ataxia. Human SCA1 platform version of the Morris water task (Logue et al.,
1997). The pattern of poor performance for the Sca1154Q/2Qpatients display mild cognitive dysfunction, including
reduction in recent and remote memory (Kish et al., mutants on the learning and memory tasks is consistent
with altered hippocampal function and, indeed, Sca1154Q/2Q1988; Bu¨rk et al., 2001); Sca1154Q/2Q mice show deficits
in memory. The Sca1154Q/2Q mice also suffer muscle wast- knockin animals exhibited an age-dependent derange-
ment of hippocampal synaptic physiology. 5- and 8-week-ing, loss of body weight, and premature death—again,
like human patients. Although body weight loss is asso- old animals displayed normal baseline synaptic trans-
mission, normal PPF, and normal LTP, but 24-week-oldciated with bulbar dysfunction (which causes difficulty
in eating) in most human patients, some individuals un- animals exhibited two alterations in baseline synaptic
function. First, there was a significant leftward shift ofdergo weight loss and wasting that is not attributable
to dysphagia or modifiable by diet (Genis et al., 1995). the fiber volley-EPSP relationship for baseline synaptic
transmission, which we take to indicate altered stimu-It is possible that brain stem dysfunction contributes to
body weight loss and premature death in Sca1154Q/2Q lus-response function for synaptic transmission in hip-
pocampal area CA1—specifically, either an enhancedmice, but detailed studies are necessary to reach a con-
clusion on this point. postsynaptic threshold responsiveness or an aug-
mented baseline presynaptic neurotransmitter release.Having succeeded in developing a mouse model that
invokes the correct temporal and spatial expression of The normal PPF in these same slices might suggest that
the presynaptic side of the terminal is not the site ofthe disease-causing mutation, some of the pathogenic
questions that are specific to SCA1 and the polygluta- change, as PPF is generally held to be a presynaptic
phenomenon, but this evidence is by no means con-mine diseases—e.g., selective neuronal vulnerability,
role of inclusions in the disease process—can begin to clusive.
The second change we observed was a decrease inbe addressed.
the maximum pEPSP slope in the mutant animals along
with an apparent attenuation of LTP. Interpretation ofLearning Deficits and Age-Dependent Impairment
the deficit in LTP is complicated by the fact that thereof Hippocampal Synaptic Transmission
in Sca1154Q/2Q Mice was altered baseline synaptic transmission as described
above, and a decrease in the maximum EPSP slope thatMice with hippocampal dysfunction have been shown to
have impaired context-based, but not cued, conditioned could be evoked with physiologic stimulation. Neverthe-
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less, LTP was diminished even when baseline transmis- Interestingly, we found both temporal and regional
alterations in mutant ataxin-1 extractability, which de-sion was normalized to 50% of the maximum and stimu-
lus intensity was normalized so that both wild-type and clines as the animals get older. The densities of the
mutant and wild-type ataxin-1 were unequal even inknockin animals evoked the same absolute EPSP slope.
We interpret our findings to indicate that there is altered 2-week-old brain extracts. It is noteworthy that the ex-
tractability of mutant ataxin-1 was higher in the cerebel-LTP in Sca1154Q/2Q animals, with the important caveat that
these apparent changes are superimposed on an altered lum than the cerebral cortex and basal ganglia. In the
cerebellum, ataxin-1 is expressed in various types ofbaseline synaptic response. Overall, our observation of
altered hippocampal synaptic physiology in the knockin neurons, but immunfluorescence analysis indicated that
its expression in granule neurons is much lower thananimals complements our observation of altered hippo-
campus-dependent learning and memory in these an- that in Purkinje neurons (data not shown). This finding
led us to propose that the extractable portion of theimals.
mutant protein in the cerebellum derived mainly from
Purkinje cells.Neuropathology in Sca1154Q/2Q Mice
An obvious pattern emerges from consideration ofReduced dendritic arborization of Purkinje neurons was
the earliest behavioral manifestations (impaired motornoted early in the course of disease in the knockin mice;
coordination), degrees of protein extractability (greatestPurkinje cell loss, though significant (20%), did not
in cerebellar tissue), electrophysiological changesoccur until the end-stage of disease. Other neuronal
(early, in Purkinje cells), sites of neurodegenerationgroups we studied, such as the hippocampal neurons,
(most notable in Purkinje cells), and NI formation (late,suffered dysfunction while not revealing notable cell
in Purkinje cells): neurons that sequester ataxin-1 intoloss. This correlates with human data, since neuronal
NIs only late in the course of the disease are also thedysfunction goes on for many years before cell loss
cells that are most severely affected by polyglutamineis a significant problem. In humans, cell loss is most
toxicity. This finding is consistent with earlier studiesprominent in Purkinje cells (the first neurons to become
on SCA1 transgenic mice showing that ataxin-1 toxicityimpaired), whereas hippocampal and cortical neuron
was much greater when it was not sequestered in NIsloss is minimal, despite the fact that these patients suffer
(Cummings et al., 1999). NIs appear in vulnerable neu-cognitive deficits (Zoghbi and Orr, 1995).
rons at an early stage in SCA1 transgenic mice, mostPolyglutamine-induced pathology in SCA1 transgenic
likely due to the very high expression of the mutant(B05) mice is characterized by cytoplasmic vacuoles,
protein (50 endogenous levels). Their relative ab-progressive loss of dendritic arborization, and Purkinje
sence in the most vulnerable neurons in human patientscell heterotopia (Clark et al., 1997). The combination
as well as the Sca1154Q/2Q mice suggests that the selectiveof Purkinje cell heterotopia and cytoplasmic vacuole
neuropathology in polyglutamine diseases reflects aformation is unique to the transgenic mice and has not
complex combination of mutant protein expression lev-been observed in tissues from SCA1 patients; as well,
els, protein solubility, and the presence of factors thatour Sca1154Q/2Q mice do not display these features. These
enable neurons to sequester ataxin-1 into NIs andmorphological differences suggest that the mechanism
thereby curb its toxicity.of Purkinje cell degeneration is not entirely the same in
This hypothesis is supported by recent findings onthe two models, which differ in both repeat length and
the pathophysiology of Alzheimer’s disease (AD) and ofmutant ataxin-1 expression levels. Since vacuole forma-
Parkinson’s disease (PD). A hallmark of pathology intion has been described for several in vitro overexpres-
both disorders is the presence of hard-to-solubilize, ubi-sion models of polyglutamine disease, it may emerge
quitin-positive deposits (senile plaques and Lewy bod-only when neurons or cells are overloaded with polyglu-
ies, respectively). But it is the soluble, not insoluble,tamine proteins.
pool of A	 that correlates with neurodegeneration in AD
(McLean et al., 1999). More recently, Walsh and col-NI Formation, Ataxin-1 Extractability,
leagues (2002) demonstrated that it is the soluble oligo-and Neuronal Vulnerability
mer form of A	 that impairs hippocampal synaptic plas-The tissue distribution of NIs in Sca1154Q/2Q mice is consis-
ticity. The situation is similar in PD: mutations of parkintent with previous reports that NI formation does not
cause early-onset autosomal recessive PD character-initiate disease in SCA1 transgenic animals (Klement et
ized by the absence of Lewy bodies (Shimura et al.,al., 1998). NIs were rare and appeared only very late in
2001). Shimura suggested that mutant parkin leads tothe course of the disease in the mutant Purkinje neurons
the accumulation of a soluble, nonubiquitinated form ofand spinal cord neurons, where we found the worst

-synuclein in parkin-deficient PD brains, acceleratingneurodegenerative pathology. On the other hand, NIs
neuronal loss and causing the earlier disease onset.already populated most neurons of the cerebral cortex,
CA1 hippocampus, and thalamus by the time mice
reached 21 weeks of age. This is reminiscent of the Factors in Polyglutamine Disease Pathogenesis
The phenotypic variability among human SCA1 patientsneuropathology of a juvenile SCA1 patient in whom NI
formation was detected in pontine neurons and some and, indeed, among patients with other polyglutamine
neurodegenerative diseases is notorious. Juvenile-cortical neurons, but not in other areas, such as re-
maining Purkinje neurons (H.Y.Z., unpublished data). In a onset cases display a widespread neuropathology that
affects many regions besides the spinocerebellar sys-study of tissue from patients with Huntington’s disease,
Kuemmerle et al. (1999) also showed that inclusions tem, they have more severe muscle wasting, and their
symptoms progress much more rapidly than in adult-form more frequently in nonaffected neuronal popula-
tions. onset disease. Interestingly, Purkinje cell loss is less
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prominent in juvenile cases, probably because there is factors contributing to the differential pattern of NI for-
insufficient time for this end-stage event to develop. To mation in this Sca1 knockin model are not known, but
our knowledge, 82 repeats are the most that have been future cross-species studies taking advantage of modifi-
found in a human SCA1 patient (who developed disease ers in the Drosophila SCA1 model (Fernandez-Funez et
at the age of 4 years). al., 2000) might help us identify such factors.
Our results show that endogenous levels of mutant This knockin mouse replicates numerous aspects of
ataxin-1 can cause neurodegenerative disease during the human disease, from progressive motor degenera-
the short life-span of the mouse if the expanded polyglu- tion to selective neuronal vulnerability and cognitive def-
tamine tract is sufficiently long. Some aspects of the icits. Not only will this model allow us to study the mech-
pathology differ slightly from those seen in adult-onset anism of these varied deficits (particularly the special
cases: the knockin mice develop inclusions in more vulnerability of certain groups of neurons to triplet repeat
brain regions than typically seen in humans. Neverthe- toxicity) in vivo, but it provides a more authentic means
less, this is consistent with the observation in SCA1 of testing interventional therapies. These mice can be
and other polyglutamine diseases that longer repeats used, for example, to test the efficacy of compounds
produce earlier and much more severe disease, with far that have proven effective in other model organisms on
more widespread pathology. We strongly suspect that multiple facets of the SCA1 phenotype (Steffan et al.,
a human SCA1 patient with 154 repeats would display an 2001).
infantile-onset disease, as has been observed in SCA7
patients with extremely long CAG tracts (Zoghbi and Experimental Procedures
Orr, 2000). Homologous recombination has been used
Generation of Sca1154Q/2Q Miceto introduce a similar length polyglutamine tract, 150
A targeting construct with 154 CAG repeats was prepared by cultur-CAG repeats, into the murine Hdh locus (Lin et al., 2001)
ing the SURE E. coli strain (Strategene) transfected with the bacterial
in an effort to duplicate HD in the mouse, but Hdh150 plasmid vector previously made for generating Sca178Q/2Q mice. The
mice failed to develop overt neurodegenerative disease. obtained plasmids were checked for the entire exon 8 of the Sca1
This strongly suggests that the protein context of the gene by sequencing and then electroporated into ES cells derived
from 129Sv/Ev strain (AB2.2). Homologous recombination was con-polyglutamine tract modulates the toxicity of the repeat,
firmed by Southern analysis as previously described (Lorenzetti etas we have suspected from human data: huntingtin with
al., 2000). Chimeric mice were crossed with C57Bl6J females. F1120 CAG repeats has caused neurological abnormality
and F2 animals are used for the studies. Both male and female F2at 5 years of age (Telenius et al., 1993) in a human child,
animals obtained from crosses between F1 heterozygous males and
while, as noted above, only 82 CAG repeats in ataxin-1 C57Bl6J wild-type females were used for behavioral and neurophys-
were required to cause symptoms in a human 4-year- iological studies.
old. Thus, protein levels, spatial and temporal distribu-
tion, protein context, and length of the polyglutamine Protein Expression and Extraction Analysis
Brain homogenates from each genotype were prepared by homoge-tract are all crucial determining factors of polyglutamine-
nizing either whole brain or specific subregions in 0.25 M Tris (pHinduced pathogenesis.
7.5) containing Complete (Roche) proteinase inhibitors. After ho-One difference between the transgenic and knockin
mogenization, samples were briefly spun at 2500 rpm on the micro-mouse models is in the stage at which NIs develop in
centrifuge (600 g), and supernatant was used for immunoblotting.
Purkinje cells and the redistribution of chaperones to For detection of aggregated forms of ataxin-1, samples were lysed
those NIs. In the overexpression model, both events in buffer containing 8 M urea, 4% SDS, 0.125 M Tris-HCl (pH 6.8),
occur quite early in pathogenesis; massive overexpres- 12 mM EDTA, 3% 	-mercaptoethanol, the proteinase inhibitor, and
0.002% bromophenol blue; incubated at 65C for 10 min; and sub-sion may mount a strong heat shock response in the
jected to SDS-PAGE. Western blot analysis was performed as pre-transgenic mouse cells, allowing early redistribution of
viously described (Skinner et al., 1997). Nitrocellulose blots werechaperones to the site of mutant polyglutamine protein.
probed with polyclonal anti-ataxin-1 (11750VII, 1:3000, 11NQ,In the knockin model, where the chaperones colocalize
1:3000) and monoclonal anti polyglutamine (1C2, 1:20000) anti-
to the NIs late, the physiologic levels of the mutant bodies.
protein may promote a much milder heat shock re-
sponse. Rotarod Analysis
What sequesters mutant ataxin-1 in NIs in various An accelerated rotating rod test allowed us to evaluate coordination
and motor skill acquisition (type 7650; Ugo Basile, Milan, Italy). Naı¨veneuronal groups? Factors that help process the mutant
F2 animals at 5 and 7 weeks of age were placed on the rod (3 cmproteins for ubiquitination or clearance may be more
diameter, 30 cm long) in four trials every day for a period of 4 days.abundant in such neurons; proteins that modify ataxin-1
Each trial lasted 10 min. The rod accelerated from 4 to 40 rpm in 5may be rate-limiting. Molecular chaperones might play
min. The time the mice spent on the rod without falling was recorded.
a role since they are known to refold or enhance clear- Behavioral scores were subjected to statistical analysis using
ance of misfolded proteins. But, although Cummings et ANOVA with repeated measures.
al. (2001) reported that overexpression of ihsp70 im-
proves neuropathology in SCA1 transgenic mice, the Visible Platform Test
mechanism by which this happens was not established; 7- to 8-week-old mice were trained on the visible platform test using
the same procedures as those described for the hidden-platformneither mutant ataxin-1 solubility nor abundance of NIs
test, with the exception that a black cube (7.5 cm  7.5 cm) waswas affected. Microtubule- or cytoskeleon-associated
attached to the top of the escape platform. The bottom of the blockmolecules could also play a role in NI formation since
was 10 cm above the surface of the platform. The platform was
disruption of the microtubule cytoskeleton leads to sup- located in the same place on each trial. Mice were given eight trials
pression of NI formation and enhancement of polyglu- a day, divided into two blocks of four trials each, on 4 consecutive
tamine toxicity in yeast expressing a mutant huntingtin days. Following the last trial, the platform was removed and a 60 s
probe trial was administered.polypeptide (Muchowski et al., 2002). At this time, the
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Pavlovian Conditioned Fear and 4F), with the identical stimulus intensity used for baseline re-
cordings.Mice were 6–8 weeks old at the start of testing. Performance in a
conditioned fear paradigm was measured as described before (Pay-
lor et al., 1994) using a Freeze Monitor system (San Diego Instru- Cerebellar Slice Physiology
ments). The test chamber was made of clear Plexiglas and sur- Sagittal cerebellar slices of 200–250 m thickness were prepared
rounded by a photobeam detection system. The floor of the test from the wild-type (P45–P79, n  4) and Sca1154Q/2Q (P46–P78, n 
chamber was a grid used to deliver an electric shock. The test 4) mice as described previously (Aiba et al., 1994; Kano et al., 1997).
chamber was placed inside a sound-attenuated chamber (Med As- Whole-cell recording was made from visually identified Purkinje cells
sociates); in the front of the chamber were windows through which using a 40water immersion objective attached to an upright micro-
the mice can be observed. A mouse was placed in the test chamber scope (Olympus, BX-50WI) (Edwards et al., 1989). Resistance of
(house lights “ON”) and allowed to explore freely for 2 min. A white patch pipettes was 3–6 M when filled with an intracellular solution
noise (80 dB), which served as the conditioned stimulus (CS), was composed of: 60 mM CsCl, 10 mM Cs D-gluconate, 20 mM TEA-
then presented for 30 s followed by a mild (2 s, 0.5 mA) foot-shock Cl, 20 mM BAPTA, 4 mM MgCl2, 4 mM ATP, 0.4 mM GTP, and 30
(the unconditioned stimulus,US). Two min. later another CS-US pair- mM HEPES, ([pH 7.3], adjusted with CsOH). The composition of
ing was presented. The mouse was removed from the chamber standard bathing solution was: 125 mM NaCl, 2.5 mM KCl, 2 mM
15–30 s later and returned to its home cage. Freezing behavior was CaCl2, 1 mM MgSO4, 1.25 mM NaH2PO4, 26 mM NaHCO3, and 20
recorded using the standard interval sampling procedure every 10 s. mM glucose, which was bubbled continuously with a mixture of
Responses (run, jump, and vocalize) to the foot-shock were re- 95% O2 and 5% CO2. Bicuculline (10 M) was always present in the
corded. Animals that did not respond to the footshock were ex- saline to block spontaneous inhibitory postsynaptic currents. Ionic
cluded from analysis. currents were recorded with a patch-clamp amplifier (Axopatch-1D,
After a defined delay interval (24 hr for Experiment 1 and 1 hr for Axon Instruments). Stimulation and online data acquisition were
Experiment 2), the mouse was placed back into the test chamber performed using the PULSE software (HEKA, Germany). The signals
for 5 min and freezing behavior was assessed every 10 s (context were filtered at 3 kHz and digitized at 20 kHz. Fitting of the decay
test). One to two hours later, the mouse was tested for its freezing phases of EPSCs was done with the PULSE-FIT software (HEKA,
to the auditory C. Environmental and contextual cues were changed Germany). For stimulation of climbing fibers and parallel fibers, a
for the auditory CS test: a black plexiglass triangular insert was glass pipette with a 5–10 m tip diameter filled with standard saline
placed in the chamber to alter its shape and spatial cues, red house was used. Square pulses (duration, 0.1 ms; amplitude, 0–100 V for
lights replaced the white house lights, the wire grid floor was covered climbing fiber stimulation, 1–10 V for parallel fiber stimulation) were
with black plexiglass, and vanilla extract was placed in the chamber applied for focal stimulation.
to alter the smell. Finally, the sound attenuated chamber was illumi-
nated with red house lights. There were two phases during the Immunohistochemistry and Immunofluorescence
auditory CS test. In the first phase (pre-CS), freezing was recorded Immunohistochemical and immunofluorescence staining were per-
for 3 min without the auditory CS. In the second phase, the auditory formed as previously described elsewhere (Skinner, et al., 1997;
CS was turned on and freezing was recorded for another 3 min. The Cummings et al., 1999). The following antisera were used to stain
number of freezing intervals was converted to a percentage of the brain tissue: rabbit polyclonal anti-ataxin-1 (11NQ), monoclonal anti-
freezing value. For the auditory CS test, the percentage freezing HDJ2/HSDJ (1:200, Neomarkers), monoclonal anti-ubiquitin (1:200,
value obtained during the pre-CS period was subtracted from the Novo Castra), and monoclonal anti-calbindin (1:1000, Sigma). For
percentage freezing value when the auditory CS was present. the quantitation of dendritic arborization, sections 20 m thick or
more were taken from of frozen fixed cerebelli of control and
Sca1154Q/2Q mice at 19 weeks of age. Samples were matched to
Spatial Learning in the Morris Water Task
minimize processing variations within each group. Sections were
2 weeks after the conditioned fear test, mice were trained in the
stained with anti-calbindin antibody which lables all cytoplasmic
Morris water task to locate a hidden escape platform in a circular
regions of purkinje cells. After washing and mounting in Vectashield,
pool (1.38 min diameter) of water. Mouse performance was recorded
37 0.5 m optical sections were accumulated with a Biorad 1024
using a tracking system called Noldus EthoVision (Leesburg, VA).
confocal microscope using the same parameters for each sample.
Each mouse was given 8 trials per day, in blocks of four trials for
The brightest continuous series of 30 sections was projected using
4 consecutive days. The time taken to locate the escape platform
the NIH Image J zprojection routine set for average intensity. From
(escape latency) and the distance traveled were determined. After
the resulting 15 m optical slabs, a rectangular subsection of a
trial 32, each animal was given a probe trial. During the probe trial,
cerebellar hemi-folium was selected from the same region and same
the platform was removed and each animal was allowed 60 s to
folium of each sample. The fluorescence intensiy profile of this slab
search the pool. The amount of time that each animal spent in each
was calculated using the plot profile routine of Image J and the
quadrant was recorded (quadrant search time). The number of times
resulting data used to develop comparative fluorescence intensity
a subject crossed the exact location of the platform during training
and average change in intensity over the course of the cell dendritic
was determined and compared with crossings of the equivalent
arbor.
location in each of the other quadrants (platform crossing). Selective
search data in the probe trial were analyzed by individual one-
Cell Countingway (quadrants) repeated ANOVAs and Newman-Keuls post-hoc
Midsagittal brain sections were prepared from 40-week-old Sca1154Q/2Qcomparison tests. Two-way (genotype X gender) ANOVA was used
mice and age-matched controls (n  3, for each group). After HEto compare the quadrant search time and platform crossing data
staining, the number of Purkinje cells and hippocampal pyramidalfor the training quadrant only between mutant and wild-type mice.
neurons in two to four adjacent sections from each brain was
counted under light microscopy and averaged. Statistical analysis
was carried out with ANOVA.Hippocampal Slice Physiology
Hippocampal slices (400m) were prepared from either 5-, 8-, or 24-
week-old Sca1154Q/2Q mice and age-matched controls, as previously Acknowledgments
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